ALK

ALK receives positive CHMP opinion for EURneffy 1mg (nasal adrenaline spray) for emergency anaphylaxis treatment in children (≥15kg)

30 January 2026 -- Hørsholm – Denmark -- Today ALK announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending expanding the marketing authorisation for EURneffy to include a 1mg nasal adrenalinespray for the emergency treatment of allergic reactions (anaphylaxis) due to...
Bøge Allé 6-8 DK-2970 Hørsholm Denmark

(+45) 4574 7576